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Abstract 
 
Objectives. The Montreal Cognitive Assessment (MoCA) is a common tool for screening 
mild cognitive impairment (MCI) and dementia. Studies in multiple clinical groups provide 
evidence for various factor structures mapping to different cognitive domains. We tested the 
factor structure of the MoCA in a large cohort of early Parkinson’s disease (PD). 
 
Materials and Methods. Complete MoCA data were available from an observational cohort 
study for 1738 patients with recent onset PD (64.6% male, mean age 67.6, SD 9.2). 
Confirmatory factor analysis (CFA) was applied to test previously defined two-factor, six-
factor, and three-factor models in the full sample and in a subgroup with possible cognitive 
impairment (MoCA <26). Secondary analysis used exploratory factor analysis (EFA; 
principal factors with oblique rotation). 
 
Results. The mean MoCA score was 25.3 (SD 3.4, range 10-30). Fit statistics in the six-
factor model (χ2/df 17.77, RMSEA 0.10, CFI 0.74, TLI 0.69, SRMR 0.07) indicated poorer fit 
than previous studies. Findings were similar in the two-factor and three-factor models. 
Exploratory factor analysis suggested an alternative six-factor solution (short-term recall, 
visuospatial-executive, attention/working memory, verbal-executive, orientation, expressive 
language), though CFA did not support the validity of the new model. 
 
Conclusions. The factor structure of the MoCA in early PD was not consistent with previous 
research. This may reflect higher cognitive performance and differing demographics in our 
sample. The results do not support a clear, clinically relevant factor structure in an early PD 
group, suggesting that the MoCA should be followed with detailed assessment to obtain 
domain-specific cognitive profiles. 
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• Previously reported factor structures in the Montreal Cognitive Assessment do not 
show a good fit in a large cohort of people with early Parkinson’s disease. 
• The Montreal Cognitive Assessment has no clear, clinically relevant factor structure 
in this cohort. 
• The Montreal Cognitive Assessment should be reserved for screening purposes; 
assessment of specific cognitive domains requires more detailed testing. 
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Introduction 
 
The Montreal Cognitive Assessment (MoCA)1 is a brief, clinician-administered test used to 
assess global cognitive function and to screen for dementia. It is also a sensitive screen for 
mild cognitive impairment (MCI)1, a state of subtle cognitive deficits that is intermediate 
between normal ageing and dementia2. In addition to providing an index of global cognitive 
function, the MoCA was designed to assess performance in different cognitive domains, 
including memory, executive function, and visuospatial skills. The test was originally 
validated in Alzheimer’s disease (AD)1, and subsequently in diverse clinical groups, 
consistently showing superior psychometric properties to previous screens3-6. 
 
The MoCA has been widely used to evaluate MCI and dementia in Parkinson’s disease 
(PD)5. Cognitive decline is associated with PD progression7,8, though it is common at all 
stages of the disease, including the newly diagnosed9. In contrast to AD, where the primary 
impairment is to memory, PD-MCI and PD dementia (PDD) are characterised by dominant 
deficits in executive function and attention, reflecting the involvement of fronto-subcortical 
circuits10. The MoCA, which includes several executive and attentional items, has 
established reliability and validity in PD11. As a result, the Movement Disorder Society clinical 
diagnostic criteria for PD-MCI recommend the MoCA for use in PD12. 
 
Although the MoCA was designed to provide an indication of global cognitive function, it was 
structured around six cognitive domains, namely short-term recall, visuospatial abilities, 
executive function, language, attention/concentration/working memory (ACWM), and 
orientation to time and place1. A much fuller assessment of each of these domains is 
possible with detailed neuropsychological testing, which then identifies distinct cognitive 
profiles. However, such testing is time-consuming and resource-intensive. Identification of 
cognitive subtypes for clinical and research purposes would be greatly facilitated if a brief 
assessment such as the MoCA were capable of adequately distinguishing and quantifying 
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the different cognitive domains. To test if the MoCA is capable of this, its internal structure 
has been assessed more rigorously. 
 
When applied to a sample including multiple dementia subtypes, confirmatory factor analysis 
(CFA) indicated that the MoCA comprised two distinct factors: memory and attentional-
executive function13. The memory factor included short-term recall, language, and orientation 
subtests, and the attentional-executive factor included attention, executive, and visuospatial 
subtests. A later CFA focused on a more specific clinical sample (AD and MCI) and tested 
several models14. The two-factor memory/attentional-executive model had a good fit to the 
observed data, but the six-factor structure postulated by Nasreddine et al.1 had a 
significantly better fit. Additionally, a single second-order factor (“cognition”) was identified. 
This included all first-order factors, and supported the unidimensionality of the MoCA as a 
measure of global cognitive function14. 
 
There has been limited exploration of the construct validity of the MoCA in PD. One study 
found that the executive, visuospatial, and memory subsections showed high sensitivity 
against a detailed, domain-focused neuropsychological test battery, though specificity and 
accuracy was adequate only for the executive section15. So far, only a single factor analysis 
of the MoCA in PD has been published. The cohort in this study (n = 357) were highly 
educated, had a short mean disease duration, and a high mean MoCA score of 26.4. As a 
result, some items (primarily in the naming and orientation sections) showed clear ceiling 
effects, being correct in over 95% of cases. Because of the lack of variance, these items 
were omitted from the subsequent exploratory factor analysis (EFA), which suggested a 
three-factor model comprising executive function, memory, and verbal attention16. This 
model has not yet been independently tested with CFA. 
 
The objective of this analysis was to extend previous research by exploring the factor 
structure of the MoCA in a very large cohort of people with PD, including patients with 
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possible MCI and dementia, in order to test its construct validity in this population. Previously 







Data was derived from the Tracking Parkinson’s study, a long-term prospective 
observational project involving 1998 recent-onset (<3.5 years disease duration at study 
enrolment) participants at 72 sites with a diagnosis of PD17. The study was conducted in 
compliance with the Helsinki Declaration18, and approved by the multicentre ethics 
committee and by local research and development departments. Exclusion criteria included 
age over 90 years, atypical parkinsonism, or a severe comorbid illness that would preclude 
full study participation. Patients with a clinical diagnosis of dementia were excluded, but 
cognitive function was otherwise not part of the eligibility criteria. For the current analysis, 
baseline data were used. Cases with incomplete MoCA data or blank values for education (n 
= 262) were excluded from analysis. 
 
CFA models were applied to the full sample (n = 1738). Due to possible ceiling effects 
(which might obscure a meaningful factor structure), we also conducted the CFA analyses 
on two sub-samples defined by a MoCA score lower than 26, encompassing probable MCI 
and more severe levels of impairment (n = 797), and lower than 21, indicating moderate to 
severe cognitive impairment (n = 157). These cutoff values have been used previously and 
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The primary measure was the MoCA version 7.1. The assessment was conducted by local 
clinical and/or research staff (generally a research nurse). A copy of the test and the 
instruction manual are freely available online (www.mocatest.org). The MoCA takes 
approximately 5-10 minutes to administer, and includes items testing word recall, figure 
copying, clock drawing, trail-making, phonemic fluency, verbal abstraction, picture naming, 
sentence repetition, forward and backward digit span, vigilance, serial subtraction, and 
temporal and spatial orientation. Some MoCA items were only available as ordinal values: 
contour, hands, and numbers on the clock drawing task had been collapsed into a single 
item (scored 0-3), as had the serial subtractions (also 0-3). The highest possible MoCA 
score is 30. Higher scores indicate better cognitive function, and a score greater than 25 
indicates normal cognition. If the subject has fewer than 13 years of education, one bonus 
point is added to the total score. The bonus point was included when reporting descriptive 
results for the total score and when identifying the MoCA<26 and MoCA<21 sub-samples, 
but the item scores used for the factor analysis were not adjusted for education level. 
 
Education is reported dichotomously as more than 12 years of education versus fewer than 
13 years of education. The first item of the Unified Parkinson’s Disease Rating Scale 
(UPDRS 1.1) was used to assess the degree of functional impairment resulting from 
cognitive deficits. This was rated by the clinician on a five-point scale (none, slight, mild, 




Statistical analysis was run on Stata version 1320. CFA with maximum likelihood estimation 
was used to test previously reported factor structures of the MoCA. Exploratory factor 
analysis (EFA; principal factors with oblique rotation) was used to identify possible 
alternative models. Because the MoCA item scores are not continuous, these analyses were 
based on summary statistics from correlation matrices. The EFA, and subsequent CFA of 
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the resulting model, were conducted on randomly-selected subgroups of the full sample; the 
similarity of these groups was confirmed using between-group comparisons (chi-square, t-
test, Mann-Whitney U test) for sex, education, age, disease duration, functional impairment 
etc. Where necessary, the normality of the distribution was evaluated by inspecting a 
histogram. 
 
The goodness-of-fit of each factor model was evaluated using the following indices: χ2/df, 
comparative fit index (CFI), Tucker-Lewis Index (TLI), root mean square error of 
approximation (RMSEA), and standarised root mean square residual (SRMR). Approximate 
values indicative of a good fit were as follows: χ2/df = 2-3, RMSEA < 0.05, CFI > 0.95, TLI > 
0.95, and SRMR < 0.0821. 
 







Descriptive statistics for the full sample and the MoCA<26 and MoCA<21 sub-samples are 
presented in Table 1. For all groups, functional impairment secondary to the cognitive 
symptoms was minimal. Men were overrepresented in the cohort, which is usual for PD 
samples22; this was more pronounced in the MoCA<26 and MoCA<21 sub-samples. The 
distribution of responses for each item are provided in Table S1. The highest percentage of 
correct answers were consistently provided for the orientation items; values for the recall 
items were typically lowest. 
 
[INSERT TABLE 1 HERE] 
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Confirmatory factor analysis 
 
Because some MoCA items were only available as ordinal values, polychoric correlation 
matrices were generated, as these accommodate both dichotomous and ordinal scores. 
Initially, these matrices had multiple blank values due to lack of variance in the data, 
precluding further analysis. Therefore, similar items were collapsed into additional ordinal 
variables, as follows: the lion, rhinoceros, and camel into a single “animals” item (scored 0-
3); date, month, year, and day into a “temporal” [orientation] item (0-4); and place and city 
into a “spatial” [orientation] item (0-2). The polychoric correlation matrix for the full sample is 
provided in Table S2. 
 
The polychoric correlation matrix was used to create a summary statistics dataset (SSD), 
which formed the basis of the CFA models. Factor-indicator correspondences used standard 
reflective measurement. Four CFA models based on previous research were tested: a two-
factor model; a six-factor model; a one-factor second-order model based on the six-factor 
model; and a three-factor model based on 20 out of the 30 MoCA items (Table 2). 
 
[INSERT TABLE 2 HERE] 
 
The two-factor model included memory and attentional-executive function13. Factor loadings 
for the two-factor model in the full sample were varied, but all were statistically significant 
(Table S3). 
 
The six-factor model comprised short-term recall, visuospatial abilities, executive function, 
ACWM, language, and orientation14. The model initially failed to converge. After noting that 
the “spatial” variable loaded perfectly onto the Orientation factor, we constrained that 
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variable’s error variance to zero: this procedure enabled an admissible solution model to 
converge. Factor loadings were again universally significant, and tended to be stronger than 
the coefficients in the two-factor model (Table S4). Phonemic fluency was loaded onto two 
latent variables (executive function and language): for both, the coefficients were relatively 
weak. 
 
The six-factor model formed the basis of a one-factor second-order model, again replicating 
Freitas et al.14. Again, the error variance for the “spatial” variable was constrained to zero. All 
of the first-order factors loaded strongly onto the higher-order factor (“cognition”), with the 
exception of orientation, which loaded more weakly. All loadings were statistically significant 
(Table S5). 
 
The three-factor model excluded ten items that were also previously excluded in the original 
factor analysis16 due to clear ceiling effects (specifically, the orientation, naming, and 
vigilance items). The subtractions test was cross-loaded onto both the executive and the 
verbal attention factors. All loadings were significant and coefficients were high, except for 
the loading of subtractions on verbal attention (Table S6). 
 
Fit statistics were computed for all of the above models (Table 3); none had a good fit. When 
tested in the MoCA<26 subgroup, correlation coefficients and fit statistics in the two-factor 
and three-factor models were generally poorer (Tables S7-S9). The six-factor models failed 
to converge. With the MoCA<21 sub-group, all tested models failed to converge, possibly 
due to the limited sample size (n = 157). In each model, we explored various strategies with 
the aim of achieving convergence (e.g. examining modification indices and specifying better 
starting values), but the possible respecifications either could not be justified theoretically, or 
did not lead to convergence. 
 
Smith – MoCA Factor Structure in Parkinson’s Disease 
 
  12 
[INSERT TABLE 3 HERE] 
 
Exploratory factor analysis 
 
In order to determine whether the MoCA’s items mapped to a different factor structure in this 
sample, we conducted an EFA. The full sample was split randomly into two subgroups of 
approximately equal size (Subgroup 1, n = 856; Subgroup 2, n = 882). The EFA was applied 
to Subgroup 1, and then tested with a CFA in Subgroup 2. Before the factor analysis was 
conducted, between-group comparisons were used to confirm that the subgroups were 
similar in relevant variables (age, disease duration, education, etc.); no significant 
differences were found. 
 
The EFA model was constrained to six factors after examining a screeplot. Factors identified 
were short-term memory (comprising recall 1-5), executive-visuospatial function (cube, 
clock, trail-making, subtractions), attention and working memory (repetition 1, digit spans 
forward and backward, vigilance, and phonemic fluency), verbal-executive (abstraction 1 and 
2 and phonemic fluency), orientation (temporal and spatial) and expressive language 
(repetition 2 and animals). Table 4 contains loadings for every item on every domain. 
 
[INSERT TABLE 4 HERE] 
 
The new model did not converge when tested with a CFA in Subgroup 2. Again, we explored 
various strategies designed to achieve convergence, but no appropriate respecifications 
emerged. Therefore, we were unable to validly compare the fit of the new model to 
previously tested ones. The model was not retained for further interpretation. 
 
A second EFA replicating Benge et al.16, constrained to three factors and excluding the 
orientation, naming, and vigilance items, was also conducted in Subgroup 1. The resulting 
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model was almost identical to that reported by Benge et al.16, the sole exception being 
backward digit span, which loaded much more strongly onto the verbal attention factor rather 
than the executive factor. Subjecting this revised model to a new CFA in Subgroup 2 again 




In a large PD cohort, we did not find a clear factor structure in the MoCA. Six-factor and one-
factor second-order models reported in AD and MCI samples14, and a two-factor model 
reported in a varied dementia group13, were not replicated in our cohort. Additionally, we 
found a poor fit for a three-factor model previously suggested as appropriate for PD. Finally, 
new EFA analyses conducted in our sample did not find a better structure to fit the observed 
data. 
 
The discrepancy between our results and previous CFA models may be explicable by 
different cognitive score distributions in the samples tested. In our full sample, the mean 
MoCA score was 25.3, and 941 (54%) were in the normal range. In contrast, the samples in 
previous CFA analyses had much lower cognitive scores, with overall means of 14.413 and 
22.414 in the cognitively impaired patients – in the latter study, the controls had a mean score 
of 24.7, below the recommended cutoff for healthy cognition. In both studies, the MCI groups 
would have been considered moderately to severely impaired in our analysis, as they had 
means of 19.613 and 18.314. Moreover, our cohort differs from these in terms of education. 
More than two-thirds of our cohort had more than 12 education years, compared to only 11% 
of one previously tested sample13. In the other study, the mean number of education years 
was 7.814. 
 
The EFA previously conducted in PD16 was based on a cohort much more similar to our 
own; mean MoCA score, disease duration, education, and the ratio of men to women were 
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all comparable, though our cohort was slightly older on average. Our analysis found a poor 
fit for their model, showing that promising EFA models do not necessarily have a good fit 
when tested with CFA in independent samples. This was also the case for the new EFA 
models that we generated in our subgroup analyses. Similar to Benge et al.’s study16, we 
found that the orientation, object naming, and digit span items had clear ceiling effects, 
reflecting their relative ease. Executive and memory items showed much greater variance, 
as was also the case for AD in Freitas et al.’s study14. Therefore, screening tests designed to 
be even shorter than the MoCA (i.e. 5 minutes or less) should minimally include sensitive 
tests of these two domains.  
 
From this, it would appear that a clear factor structure to the MoCA may emerge in cohorts 
that are characterised by more severe cognitive impairment, where a consistent and 
theoretically reasonable pattern of errors might emerge. However, this factor structure is 
obscured in cognitively normal or mildly impaired samples, where by definition most 
participants will provide correct responses to the majority of the MoCA’s items. We sought to 
test this hypothesis in a subset of our cohort with more severe impairment (MoCA<21), but 
the model failed to converge, potentially due to the small sample size. Future research with a 
larger cohort of moderately or severely impaired PD patients would be useful to establish 
whether the factor structure reported in other dementias is evident in this context. 
 
The major strength of our analysis is the very large sample size (n = 1738), which permitted 
a well-powered sub-group analysis with a MoCA<26 sub-group (n = 797). However, a 
relatively large number of cases (n = 262) from the full dataset were excluded due to missing 
data. An additional limitation was that the sample was not fully representative of the PD 
population at large, given the eligibility criteria requiring diagnosis <3.5 years before study 
enrolment. 
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Our results suggest that the MoCA should be reserved for screening purposes, or for 
assessment of global level of cognitive function, as is suggested by the Movement Disorder 
Society12. The MoCA is a reliable and valid instrument for these purposes. However, detailed 
neuropsychological testing remains the gold standard for accurately measuring performance 




In conclusion, our results do not support the existence of a clear factor structure to the 
MoCA in a large cohort of PD patients with overall normal or mildly impaired cognition. 
Comparisons to previous studies suggest that a clinically significant factor structure may 
emerge in samples with moderate to severe dementia. The MoCA may be useful for 
identifying meaningful subtypes in such cases, but our evidence suggests that it cannot do 
so in PD-MCI. Therefore, for the present, subtyping people with PD-MCI should rely on the 
established procedure of detailed neuropsychological testing. The MoCA should be used for 
either screening purposes or for assessing global cognitive function in PD. 
 
Data availability statement 
 
The data that support the findings of this study are available from the Tracking Parkinson's 
core committee. Restrictions apply to the availability of these data, which were used under 
license for this study. Data are available from the authors with the permission of the core 
committee. 
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Table 1. Descriptive statistics for the full sample and sub-samples. 
 
  Full sample MoCA<26 MoCA<21 
Sample size 1738 797 157 
Age 67.6 (9.2) 69.9 (8.5) 73.4 (7.3) 
Disease duration (years) 3.2 (3.1) 3.0 (2.7) 3.5 (4.1) 
MDS UPDRS 1.1 0.5 (0.7) 0.7 (0.8) 0.9 (1.0) 
MoCA total score 25.3 (3.4) 22.4 (2.7) 17.9 (2.2) 
Male 1123 (64.6%) 564 (70.8%) 117 (74.5%) 
>12 years education 1176 (67.6%) 492 (61.7%) 76 (48.4%) 
<13 years education 562 (32.3%) 305 (38.3%) 81 (51.6%) 
    
Data are n (%) or mean (standard deviation). 
MDS = Movement Disorder Society, MoCA = Montreal Cognitive Assessment,  
UPDRS = Unified Parkinson's Disease Rating Scale. 
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Table 2. Summary of models tested with confirmatory factor analysis. 
Item Two-factor model Six-factor models Three-factor model 
Trail-making Attentional-executive Executive Executive 
Phonemic fluency Attentional-executive Executive* Executive 
Abstraction 1 Attentional-executive Executive Executive 
Abstraction 2 Attentional-executive Executive Executive 
Animals Memory Language Not included 
Repetition 1 Memory Language Verbal attention 
Repetition 2 Memory Language Verbal attention 
Recall 1 Memory ST Recall ST Recall 
Recall 2 Memory ST Recall ST Recall 
Recall 3 Memory ST Recall ST Recall 
Recall 4 Memory ST Recall ST Recall 
Recall 5 Memory ST Recall ST Recall 
Digits forward Attentional-executive ACWM Verbal attention 
Digits backward Memory ACWM Executive 
Vigilance Attentional-executive ACWM Not included 
Subtractions Attentional-executive ACWM Executive† 
Cube Attentional-executive Visuospatial Executive 
Clock Attentional-executive Visuospatial Executive 
Temporal Memory Orientation Not included 
Spatial Memory Orientation Not included 
  
* Phonemic fluency was cross-loaded onto the language factor in the six-factor model. † Subtractions was cross-
loaded onto the Verbal Attention factor. ACWM = attention, concentration, and working memory; ST = short term. 
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Table 3. Goodness-of-fit statistics for the confirmatory factor analyses. 
 




χ2M 4031.53 2753.84 2994.20 1623.26 
dfM 169 155 164 101 
p <0.001 <0.001 <0.001 <0.001 
pclose-fit H0 <0.001 <0.001 <0.001 <0.001 
χ2/df  23.86 17.77 18.26 16.07 
RMSEA (90% CI) 0.115 (0.112-0.118) 0.098 (0.095-0.101) 0.100 (0.097-0.103) 0.093 (0.089-0.097) 
CFI 0.62 0.74 0.72 0.81 
TLI 0.57 0.69 0.68 0.77 
SRMR 0.09 0.07 0.08 0.06 
     
All models were tested in the full sample (n = 1738). CFI = comparative fit index, CI = confidence interval, RMSEA = 
root mean square error of approximation, SRMR = standardised root mean square residual, TLI = Tucker-Lewis Index. 
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Trail-making 0.03 0.60 0.03 0.04 0.13 -0.07  
Phonemic fluency 0.03 0.08 0.22 0.23 0.13 0.06  
Abstraction 1 -0.02 0.11 -0.08 0.59 0.14 0.02  
Abstraction 2 0.06 0.06 -0.08 0.68 0.07 0.23  
Animals 0.00 0.40 -0.06 0.13 -0.18 0.45  
Repetition 1 0.04 0.00 0.55 0.09 -0.15 0.27  
Repetition 2 0.06 -0.13 0.13 0.22 0.29 0.53  
Recall 1 0.35 0.10 0.02 0.23 -0.10 -0.22  
Recall 2 0.65 0.05 0.02 0.13 -0.11 -0.18  
Recall 3 0.69 0.04 -0.01 0.06 -0.01 -0.05  
Recall 4 0.74 -0.02 -0.01 -0.07 0.05 0.23  
Recall 5 0.74 -0.05 -0.02 -0.05 0.04 0.19  
Digits forward -0.02 0.06 0.72 -0.12 -0.10 -0.07  
Digits backward -0.05 0.18 0.48 -0.18 0.27 0.18  
Vigilance 0.05 -0.13 0.32 0.17 0.27 -0.06  
Subtractions -0.08 0.33 0.12 0.11 0.13 -0.03  
Cube -0.07 0.53 -0.06 0.24 0.05 0.08  
Clock 0.08 0.59 0.15 -0.01 -0.18 0.08  
Temporal 0.16 0.29 -0.08 -0.28 0.45 -0.09  
Spatial -0.05 -0.04 -0.08 0.17 0.84 0.08  
  
This analysis was conducted on the full sample (Subgroup 1, n = 856). Values given as correlation 
coefficients. For each item, the strongest loading is in bold text. 
 
AWM = attention and working memory; ST = short term.  
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Table S1. Distribution of responses for each MoCA item. 
Item Full sample MoCA<26 MoCA<21 
Trail-making 79.6 64.2 29.3 
Phonemic fluency 67.8 52.8 30.6 
Abstraction 1 79.8 66.8 37.6 
Abstraction 2 82.0 70.6 44.6 
Lion 99.5 99.0 97.5 
Rhinoceros 91.2 86.2 72.6 
Camel 98.9 97.9 94.9 
Repetition 1 90.3 83.4 67.5 
Repetition 2 82.5 70.8 51.6 
Recall 1 50.9 29.2 9.6 
Recall 2 64.2 40.8 19.1 
Recall 3 54.9 29.3 8.3 
Recall 4 41.9 18.9 5.1 
Recall 5 54.3 29.4 10.2 
Digits forward 95.3 91.3 84.1 
Digits backward 90.6 83.8 67.5 
Vigilance 88.5 79.9 65.0 
Cube 76.6 60.0 29.3 
Date 90.7 84.4 73.9 
Month 99.3 98.9 97.5 
Year 99.1 98.1 93.0 
Day 98.4 96.7 91.7 
Place 99.0 98.4 96.2 
City 99.8 99.6 99.4 
Subtractions (0 correct) 2.4 5.0 12.7 
Subtractions (1 correct) 7.2 13.4 25.5 
Subtractions (2-3 correct) 26.4 33.8 36.3 
Subtractions (4-5 correct) 64.1 47.8 25.5 
Clock (0 elements correct) 0.9 2.0 5.7 
Clock (1 element correct) 4.5 9.9 23.6 
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Clock (2 elements correct) 18.5 29.9 42.7 
Clock (3 elements correct) 75.6 58.2 28.0 
 
All values are percentages (%). For all items except subtractions and clock, values represent correct responses. 
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Abstraction 1 Abstraction 2 Animals Repetition 1 Repetition 2 Recall 1 Recall 2 Recall 3 Recall 4 Recall 5 
Trail-making 1            
Phonemic fluency 0.18 1           
Abstraction 1 0.30 0.25 1          
Abstraction 2 0.24 0.26 0.54 1         
Animals 0.34 0.12 0.19 0.24 1        
Repetition 1 0.26 0.25 0.26 0.22 0.09 1       
Repetition 2 0.22 0.23 0.25 0.30 0.22 0.50 1      
Recall 1 0.32 0.18 0.25 0.18 0.22 0.20 0.16 1     
Recall 2 0.27 0.20 0.26 0.24 0.15 0.24 0.22 0.54     
Recall 3 0.27 0.21 0.23 0.28 0.12 0.17 0.21 0.41 1    
Recall 4 0.24 0.21 0.21 0.22 0.21 0.19 0.23 0.27 0.45 1   
Recall 5 0.25 0.17 0.23 0.16 0.17 0.19 0.25 0.27 0.41 0.56 1  
Digits forward 0.10 0.19 0.26 0.07 0.06 0.38 0.19 0.16 0.20 0.20 0.23 1 
Digits backward 0.34 0.24 0.18 0.18 0.22 0.25 0.16 0.19 0.08 0.17 0.13 0.17 
Vigilance 0.25 0.26 0.16 0.20 0.15 0.14 0.25 0.22 0.15 0.26 0.20 0.25 
Subtractions 0.31 0.13 0.20 0.26 0.13 0.10 0.10 0.17 0.16 0.17 0.11 0.16 
Cube 0.50 0.24 0.29 0.33 0.30 0.25 0.25 0.22 0.22 0.29 0.18 0.42 
Clock 0.44 0.17 0.22 0.23 0.26 0.21 0.19 0.22 0.25 0.29 0.25 0.24 
Temporal 0.23 0.12 0.16 0.07 0.13 0.03 0.15 0.16 0.19 0.18 0.21 0.23 
Spatial 0.20 0.15 0.21 0.19 0.13 0.17 0.34 –0.06 0.07 0.07 0.14 0.02 
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Vigilance Subtractions Cube Clock Temporal Spatial     
Digits forward 1            
Digits backward 0.29 1           
Vigilance 0.23 0.34 1          
Subtractions 0.19 0.31 0.16 1         
Cube 0.22 0.20 0.23 0.31 1        
Clock 0.23 0.26 0.23 0.25 0.42 1       
Temporal 0.08 0.25 0.22 0.30 0.23 0.29 1      
Spatial 0.14 0.30 0.25 0.13 0.11 –0.01 0.37 1     
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Table S3. Factor loadings for each item by cognitive domain (two-factor model). 
 


















Animals 0.32 (0.02)** 
  
Repetition 1 0.38 (0.02)** 
  
Repetition 2 0.42 (0.02)** 
  
Recall 1 0.54 (0.02)** 
  
Recall 2 0.67 (0.02)** 
  
Recall 3 0.72 (0.01)** 
  
Recall 4 0.67 (0.02)** 
  
























Temporal 0.35 (0.02)** 
  
Spatial 0.22 (0.03)** 
  
    
This model was tested in the full sample (n = 1738). Values given as 
correlation coefficient (standard error). * p < 0.05, ** p < 0.001. 
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Table S4. Factor loadings for each item by cognitive domain (six-factor model). 
 
Item Executive Language ST Recall ACWM Visuospatial Orientation 
Trail-making 0.65 (0.02)** 
     
Phonemic fluency 0.29 (0.04)** 0.16 (0.05)* 
    
Abstraction 1 0.55 (0.02)** 
     
Abstraction 2 0.55 (0.02)** 
































   
Digits forward 
























     
0.37 (0.02)** 
Spatial† 
     
1.00 (8.8x10-18)** 
       
This model was tested in the full sample (n = 1738). Values given as correlation coefficient (standard error). * p < 0.05, 
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Table S5. Factor loadings for each item by cognitive domain (one-factor second-order 
model). 
 
Item Executive Language ST Recall ACWM Visuospatial Orientation 
Cognition 0.99 (0.02)** 0.71 (0.03)** 0.60 (0.02)** 0.80 (0.02)** 0.85 (0.02)** 0.33 (0.02)** 
Trail-making 0.62 (0.02)** 
     
Phonemic fluency 0.34 (0.05)** 0.12 (0.05)* 
    
Abstraction 1 0.57 (0.02)** 
     
Abstraction 2 0.56 (0.02)** 
































   
Digits forward 
























     
0.37 (0.02)** 
Spatial† 
     
1.00 (2.0x10-17)** 
       
This model was tested in the full sample (n = 1738). Values given as correlation coefficient (standard error). * p < 0.05, 
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Table S6. Factor loadings for each item by cognitive domain (three-factor model). 
 
Item Executive ST Recall Verbal Attention 
 
Trail-making 0.66 (0.02)**   
 
Phonemic fluency 0.40 (0.02)**   
 
Abstraction 1 0.54 (0.02)**   
 
Abstraction 2 0.54 (0.02)**   
 
Repetition 1   0.77 (0.02)** 
 
Repetition 2   0.62 (0.02)** 
 
Recall 1  0.54 (0.02)**  
 
Recall 2  0.70 (0.02)**  
 
Recall 3  0.78 (0.02)**  
 
Recall 4  0.69 (0.02)**  
 
Recall 5  0.69 (0.02)**  
 
Digits forward   0.47 (0.02)** 
 
Digits backward 0.44 (0.02)**   
 
Subtractions 0.45 (0.02)**  0.00 (0.00) 
 
Cube 0.65 (0.02)**   
 





This model was tested in the full sample (n = 1738). Values given as correlation coefficient (standard 
error). * p < 0.05, ** p < 0.001. ST = short term. 
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Table S7. Factor loadings for each item by cognitive domain (two-factor model, MoCA<26 
sample). 
Item Memory Attentional-Executive 
 














Animals -0.06 (0.04) 
  
Repetition 1 -0.01 (0.04) 
  
Repetition 2 -0.01 (0.04) 
  
Recall 1 0.38 (0.04)** 
  
Recall 2 0.61 (0.03)** 
  
Recall 3 0.68 (0.03)** 
  
Recall 4 0.59 (0.03)** 
  
























Temporal 0.00 (0.04) 
  
Spatial -0.13 (0.04)*   
 
    
Values given as correlation coefficient (standard error). * p < 0.05, ** p < 0.001. 
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Table S8. Factor loadings for each item by cognitive domain (three-factor model, MoCA<26 
sample). 
 
Item Executive ST Recall Verbal Attention 
 
Trail-making 0.59 (0.04)**   
 
Phonemic fluency 0.16 (0.04)**   
 
Abstraction 1 0.33 (0.05)**   
 
Abstraction 2 0.36 (0.05)**   
 
Repetition 1†  
 1.00 (3.7x10-16)** 
 
Repetition 2   0.44 (0.03)** 
 
Recall 1  0.37 (0.04)**  
 
Recall 2  0.61 (0.03)**  
 
Recall 3  0.68 (0.03)**  
 
Recall 4  0.60 (0.03)**  
 
Recall 5  0.55 (0.03)**  
 
Digits forward   0.31 (0.03)** 
 
Digits backward 0.28 (0.04)**   
 
Subtractions 0.28 (0.04)**   
 
Cube 0.61 (0.04)**   
 





This model was tested in the full sample (n = 1738). Values given as correlation coefficient (standard 
error). * p < 0.05, ** p < 0.001. † Error variance constrained to 0. ST = short term. 
Repetition 1 loaded almost perfectly onto Verbal Attention, preventing the model from converging. 
Therefore, this item’s variance was constrained to 0. 
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Table S9. Goodness-of-fit statistics for the confirmatory factor analyses (MoCA<26 sample). 
Statistic Two-factor model Three-factor model 
χ2M 1966.62 796.32 
dfM 169 102 
p <0.001 <0.001 
pclose-fit H0 <0.001 <0.001 
χ2/df  11.64 7.80 
RMSEA (90% CI) 0.116 (0.111-0.120) 0.092 (0.086-0.098) 
CFI 0.35 0.64 
TLI 0.27 0.58 
SRMR 0.10 0.07 
   
CFI = comparative fit index, CI = confidence interval, RMSEA = root mean square error of approximation,  
SRMR = standardised root mean square residual, TLI = Tucker-Lewis Index. 
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Table S10. Goodness-of-fit statistics for the confirmatory factor analysis (new three-factor 
model). 




pclose-fit H0 <0.001 
χ2/df  15.98 





CFI = comparative fit index, CI = confidence interval, RMSEA = root mean square error of approximation,  
SRMR = standardised root mean square residual, TLI = Tucker-Lewis Index. 
 
 
